Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Publication of HN2009001203ApublicationCriticalpatent/HN2009001203A/en
ESTA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I) : LA PRESENTE INVENCION INVENCION SE RELACIONA CON NUEVOS DERIVADOS DE ESTER O AMIDA DE INDAZOLOLILO, COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN DICHOS DERIVADOS, PROCESOS PARA PREPARAR DICHOS NUEVOS DERIVADOS Y EL USO DE DICHOS DERIVADOS COMO MEDICAMENTOSTHIS INVENTION REFERS TO FORMULA COMPOUNDS (I): THIS INVENTION INVENTION IS RELATED TO NEW DERIVATIVES OF ESTER OR AMIDA OF INDAZOLOLILO, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH DERIVATIVES, PROCESSES TO PREPARE SUCH DERIVATIVE DERIVATIVES AND THE DERIVATIVES
HN2009001203A2006-12-212009-06-19
DERIVATIVES OF ESTER AND AMIDA DEINDAZOLILO FOR THE TREATMENT OF DISEASES MEDIATED BY A GLUCOCORTICOID RECEPTOR
HN2009001203A
(en)
NEW DERIVATIVES OF 6-TRIALZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS.
FORMS OF POLYMORPHES OF THE (2S) - (4E) -N-METHYL-5- (3-ISOPROPOXIPIRIDIN) IL] -4-PENTEN-2-AMINA FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM